Diabetic Footwear Market to Reach $13.9 Billion by 2035

Diabetic footwear market was valued at $7.3 billion in 2025 and is projected to reach $13.9 billion by 2035, expanding at a CAGR of 6.7% from 2026 to 2035. The rising global prevalence of diabetes is an important healthcare-related driver of demand for specialized footwear. According to the International Diabetes Federation (IDF), an estimated 589 million adults aged 20–79 were living with diabetes globally in 2024, representing 11.1% of this age group, while approximately 252 million adults were estimated to have undiagnosed diabetes. The IDF projects that the number of adults living with diabetes will reach approximately 853 million by 2050. This growing patient population is increasing the need for footwear designed to accommodate sensitive feet, provide adequate space, reduce friction, and support daily mobility. The extent of demand for specialized footwear also depends on consumers’ foot-health risks, purchasing power, access to suitable products, and healthcare-provider recommendations.

Browse the full report description of “Diabetic Footwear Market Size, Share & Trends Analysis Report, By Product Type (Diabetic Shoes, Diabetic Sandals, Diabetic Slippers & Custom-Made/Orthopedic Diabetic Footwear), By Distribution Channel (Specialty Stores, Hospital & Clinic-Based Channels, Pharmacies, Online Retail & Other Channels), By End User (Men, Women & Children), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/diabetic-footwear-market

Diabetes-related foot complications create an additional need for protective and therapeutic footwear across healthcare and consumer applications. The World Health Organization (WHO) identifies nerve damage and reduced blood circulation as complications that can contribute to foot ulcers and, in severe cases, lower-limb amputation. According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 12% of people with diabetes develop diabetic foot ulcers during their lifetime; CDC data also recorded about 130,000 diabetes-related hospital discharges involving lower-extremity amputation in 2016. These clinical risks support demand for diabetic shoes, therapeutic sandals, slippers, and custom-made or orthopedic footwear. Among product categories, diabetic shoes are expected to remain a major segment because they can provide greater foot coverage for routine activities while incorporating extra depth, wider toe boxes, cushioning, removable insoles, and adjustable closures to accommodate individual fitting needs.

Diabetic Shoes Segment to Drive Market Growth

The diabetic shoes segment is expected to account for a significant share of the market because specialized footwear can accommodate foot sensitivity, altered foot structure, pressure points, and orthotic requirements associated with diabetes-related complications. Unlike standard shoes, diabetic footwear may be designed with additional internal volume, wider fitting options, smooth interior surfaces, and removable footbeds to accommodate therapeutic inserts. These construction features are particularly relevant for people who require additional space or need to minimize rubbing from seams and restrictive materials. Demand is also supported by the use of specialized shoes for everyday walking and mobility, extending the product category beyond footwear used exclusively in clinical environments. However, the appropriate footwear type varies according to an individual's foot condition, and people with active ulcers or high-risk foot complications may require clinician-prescribed offloading devices rather than ordinary diabetic shoes.

Manufacturers are developing products for more specific foot-care requirements, including pressure redistribution and wound management. DARCO International's DUO Pro Wound Care Shoe, for example, is designed for diabetic foot syndrome, open wounds, minor ulceration, and pressure offloading. According to the company's product information, its Aircore insole combines cushioning material with a removable peg system that can be customized to redistribute pressure around targeted areas. DARCO also claims that the product can reduce plantar pressure by up to 40% compared with competitor postoperative shoes. This is a manufacturer-reported performance claim, not an independently established comparison across all footwear or patient groups. The product illustrates the development of specialized footwear solutions for clinical foot-care needs, where adjustability, pressure management, and compatibility with wound-care protocols are important considerations. Such product differentiation can expand the range of available solutions across preventive footwear and more specialized therapeutic applications.

Recent Developments

• In October 2025, Enovis Corporation completed the sale of its Dr Comfort diabetic shoe business to Promus Equity Partners for up to $60 million, including $45 million upfront and up to $15 million in milestone payments. The transaction enabled Enovis to streamline its portfolio while transferring the established diabetic footwear business to Promus for continued development.

• In 2025, DARCO International introduced the DUO Pro Wound Care Shoe, an offloading solution designed for diabetic foot ulcers, open wounds, and pressure injuries. The footwear combines a dual-hardness post-operative shoe with an Aircore Offloading Insole and removable peg system for customized pressure relief, with DARCO reporting up to a 40% reduction in plantar pressure compared with competitor post-operative shoes.

Market Coverage

• The market size available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segments Covered-
  • By Product Type
  • By Distribution Channel
  • By End User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape – DARCO International, Inc., Drew Shoe Corporation, Hochste Healthcare Private Limited, OrthoGenix Pty Ltd., and Podartis S.r.l., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Diabetic Footwear Market Report Segment

By Product Type

• Diabetic Shoes
• Diabetic Sandals
• Diabetic Slippers
• Custom-Made/Orthopedic Diabetic Footwear

By Distribution Channel

• Specialty Stores
• Hospital & Clinic-Based Channels
• Pharmacies
• Online Retail
• Other Channels

By End User

• Men
• Women
• Children

Diabetic Footwear Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/diabetic-footwear-market